Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2010
05/27/2010US20100130518 Mapk/erk kinase inhibitors
05/27/2010US20100130517 New 4,8-diphenyl-polyazanaphthalene derivatives
05/27/2010US20100130516 Purinyl derivatives and their use as potassium channel modulators
05/27/2010US20100130512 Fused-ring heterocycle opioids
05/27/2010US20100130510 Compounds for inflammation and immune-related uses
05/27/2010US20100130506 Organic Compounds
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130487 Spiro-oxindole compounds and their uses as therapeutic agents
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130458 Polymorphs of fluticasone furoate and process for preparation thereof
05/27/2010US20100130457 Phenothiazine Derivatives for Treatment of Asthma
05/27/2010US20100130452 Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis
05/27/2010US20100130442 Lung Injury Treatment
05/27/2010US20100130441 Use of vitamin b12 for treatment of mucosal lesions
05/27/2010US20100129393 Novel use of l. undulata extract as therapeutics for allergic diseases
05/27/2010US20100129380 Antibodies Against IL-25
05/27/2010US20100129365 Treatment of inflammation using bst2 inhibitor
05/27/2010US20100129296 Extract of trigonella foenum-graecum
05/27/2010CA2744343A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189454A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
05/26/2010EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2188015A2 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
05/26/2010EP2187956A2 Use of a laminin peptide as a therapeutic agent
05/26/2010EP2187952A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents
05/26/2010EP2187950A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
05/26/2010EP2187949A2 Use of glp-1 as a therapeutic agent
05/26/2010EP2187948A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187947A2 Use of calcitonin as anti-angiogenic agent
05/26/2010EP2187946A1 Use of a peptide as a therapeutic agent
05/26/2010EP2187945A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187934A1 Use of fertirelin and delta-endorphin as therapeutic agents
05/26/2010EP2187931A2 Use of a combination of cart peptides as a therapeutic agent
05/26/2010EP2187930A2 Trap-14 as a therapeutic agent
05/26/2010EP2187929A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187924A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187917A2 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
05/26/2010EP2187915A2 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
05/26/2010EP2187909A1 Use of bpp-b as a therapeutic agent
05/26/2010EP2187907A2 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
05/26/2010EP2187901A2 Therapeutic use of neuropeptide ei and a acth 7-38 and compositions thereof
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010CN1984656B Cancer treatment method
05/26/2010CN1840002B Chinese medicinal preparation for treating chronic obstructive lung disease (COPD) and preparation method thereof
05/26/2010CN1709497B Miao-medicine composition and its use
05/26/2010CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
05/26/2010CN1655823B Topically applicable pharmaceutical preparation
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1604795B Combination motif immune stimulatory oligonucleotides with improved activity
05/26/2010CN101715441A Quinoline derivatives as CRTH2 receptor ligands
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712679A Acylamide class compound, medicine composition, preparation method and application thereof
05/26/2010CN101712631A Derivates of rupestonic acid and uses thereof
05/26/2010CN101711856A Oral liquid for cold
05/26/2010CN101711845A Traditional Chinese medicine for treating lung cancer
05/26/2010CN101711830A Traditional Chinese medicine composition for treating chronic bronchitis
05/26/2010CN101711825A Preparation method of rhizoma pinelliae preparata
05/26/2010CN101711824A Chinese medicinal preparation for external use for stopping cough and diarrhea in children
05/26/2010CN101711823A Medicine used for treating asthmatic bronchitis
05/26/2010CN101711822A Traditional Chinese medicine granules for treating common cold and influenza
05/26/2010CN101711818A Natural galenical preparation for preventing and treating respiratory diseases of livestock and poultry and preparation method thereof
05/26/2010CN101711808A Soft capsule used for clearing away heat and toxic materials and preparation method thereof
05/26/2010CN101711784A Preparation method of serissa serissoide extractive
05/26/2010CN101711770A Fomitopsis officinalis (Vill. : Fr.) Bond. polysaccharide particle preparation and preparation method thereof
05/26/2010CN101711761A Compositions for prevention and treatment of cold and influenza-like symptoms and use methods thereof.
05/26/2010CN101711758A Application of apigenin in preparing medicament for preventing and treating diseases caused by ischemic injuries of humans
05/26/2010CN101152357B Proprietary Chinese medicine for treating tonsillitis and method of processing the same
05/26/2010CN101129748B Proprietary Chinese medicine for treating cancer of the lungs and method of preparing the same
05/26/2010CN101095688B Application of mannose in the preparation of medicine for treating pulmonary inflammation disease
05/26/2010CN101081092B beverage for expelling toxin and treating melancholy
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101049492B Preparation for treating allergic rhinitis
05/26/2010CN101049325B Method for preparing processed product of Chinese ephedra of Chinese traditional medicine
05/26/2010CN101032484B Capsule type tiotropium bromide inhalation powder
05/26/2010CN101015590B Jiawei Fuzheng Jiedu powder for treating chicken renal infectious bronchitis and its preparing process
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723373 3-(Aryl or heteroaryl)sulfonyl- or sulfinyl-1-indoleacetic acid derivatives, e.g., 3 -[(4-chlorophenyl)sulfonyl]-2,5-dimethyl-1H-indol-1-acetic acid; treating asthma, rhinitis and other diseases in which raised levels of PGD2 or its metabolites
05/25/2010US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
05/25/2010US7723341 Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer
05/25/2010US7723340 mitogen-activated protein kinase 8 inhibitors, used for treating or preventing cancer, cardiovascular diseases, renal diseases, autoimmune disorders, inflammatory disorders, vision defects, ischemia-reperfusion injuries, pain and hypertension
05/25/2010US7723334 Highly selective norepinephrine reuptake inhibitors and methods of using the same
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010CA2508307C A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb)
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2439295C Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/25/2010CA2433128C Novel quinuclidine derivatives and medicinal compositions containing the same
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2321920C 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
05/25/2010CA2314156C Pyrrole substituted 2-indolinone protein kinase inhibitors
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 878